Sylvie 20,20 µg + 75 µg, sugar-coated tablets
Sylvie 30,30 µg + 75 µg, sugar-coated tablets
Ethinylestradiol + Gestodene
Sylvie 20, Sylvie 30 is a combined oral contraceptive.
Each tablet contains a small amount of two different female hormones. These are: ethinylestradiol
(estrogen) and gestodene (progestogen). Due to the low hormone content, Sylvie 20, Sylvie 30
is classified as a low-dose contraceptive.
Indications for use
Prevention of pregnancy.
Oral contraception is a very effective method of preventing pregnancy. During correct use of oral hormonal contraceptives, the likelihood of becoming pregnant is very low.
1
Before starting to take Sylvie 20, Sylvie 30, you should read the information about blood clots (thrombosis) in section 2. It is especially important to read about the symptoms of blood clots (see section 2 "Blood Clots").
Sylvie 20, Sylvie 30 should not be taken if the patient has any of the conditions listed below. If the patient has any of these conditions, they should inform their doctor. The doctor will discuss with the patient which other contraceptive method would be more suitable.
2
When should you contact your doctor?
You should see your doctor immediately
If you are taking Sylvie 20, Sylvie 30 in any of the situations listed below, close medical supervision is necessary.
Tell your doctor if you have any of these conditions or if they get worse while taking Sylvie 20, Sylvie 30.
If any of the above conditions occur for the first time or worsen while taking Sylvie 20, Sylvie 30, you should contact your doctor.
Taking combined hormonal contraceptives, such as Sylvie 20, Sylvie 30, is associated with an increased risk of blood clots, compared to not taking them. In rare cases, a blood clot can block a blood vessel and cause serious complications.
Blood clots can occur:
Not everyone who gets a blood clot will recover completely. In rare cases, the effects of a blood clot can be long-term or, very rarely, fatal.
3
You should see your doctor immediately if you notice any of the following symptoms.
Are you experiencing any of these symptoms?
Why might the patient be suffering from
these symptoms?
If you are unsure, you should see your doctor, as some of these symptoms, such as coughing or shortness of breath, can be mistaken for less serious conditions, such as a respiratory infection (e.g., a cold).
Pulmonary embolism
Symptoms usually occur in one eye:
4
| |
| Blood clots blocking other blood vessels |
The risk of blood clots in veins is highest during the first year of taking combined hormonal contraceptives for the first time. The risk may also be higher when restarting combined hormonal contraceptives (the same or a different medication) after a break of 4 weeks or more.
After the first year, the risk decreases, but it is always higher than when not taking combined hormonal contraceptives.
If you stop taking Sylvie 20, Sylvie 30, the risk of blood clots returns to normal within a few weeks.
The risk of blood clots associated with Sylvie 20, Sylvie 30 is small, but some factors can increase this risk.
The risk is higher:
The risk of blood clots increases with the number of risk factors present.
Long-distance air travel (over 4 hours) may temporarily increase the risk of blood clots, especially if you have other risk factors.
It is essential to tell your doctor if any of these risk factors apply to you, even if you are not sure. Your doctor may decide to stop Sylvie 20, Sylvie 30.
If there is a change in the status of any of the above conditions while taking Sylvie 20, Sylvie 30, such as a family member being diagnosed with a blood clot without a known cause or if you gain weight significantly, you should inform your doctor.
Similar to blood clots in veins, blood clots in arteries can cause serious complications, such as a heart attack or stroke.
6
It is worth noting that the risk of a heart attack or stroke associated with Sylvie 20, Sylvie 30 is very small, but it may increase:
If you have more than one of these conditions or if any of them are particularly severe, the risk of a blood clot may be even higher.
You should inform your doctor if there is a change in the status of any of the above conditions while taking Sylvie 20, Sylvie 30, such as starting to smoke, a family member being diagnosed with a blood clot without a known cause, or if you gain weight significantly.
In the event of symptoms suggesting a blood clot, you should stop taking the tablets and consult your doctor immediately (see also "When to contact your doctor").
In women who take oral contraceptives, breast cancer is slightly more common than in women of the same age who do not take them. It is not known whether this difference is caused solely by the use of hormonal contraceptives. The reason may be, for example, that women who use hormonal contraceptives are more likely to have regular check-ups and breast cancer is detected earlier. The described difference in the incidence of breast cancer decreases gradually, and 10 years after stopping oral contraceptives, the risk is the same as for women who have never taken them.
Rare cases of benign or, even more rarely, malignant liver tumors have been reported in women taking combined oral contraceptives. If severe abdominal pain occurs, you should see your doctor as soon as possible.
There are reports of a higher incidence of cervical cancer in women who have taken oral contraceptives for a long time. However, this relationship may not be related to taking the tablets but may be due to differences in sexual practices.
Some women who take hormonal contraceptives, including Sylvie 20, Sylvie 30, have reported depression or mood swings. Depression can be severe and sometimes lead to suicidal thoughts. If mood changes or symptoms of depression occur, you should see your doctor as soon as possible for further medical advice.
7
Some medications may affect the action of Sylvie 20, Sylvie 30 and may reduce its effectiveness. These include medications used to treat:
Combined oral contraceptives may affect the metabolism of other medications, whose levels in the blood and tissues may increase (e.g., cyclosporin) or decrease (e.g., lamotrigine).
You should tell your doctor or pharmacist about all medications you are currently taking or have recently taken, as well as any medications you plan to take.
Sylvie 20, Sylvie 30 should not be taken if you have hepatitis C and are taking antiviral medications containing ombitasvir with paritaprevir and ritonavir, dasabuvir, glecaprevir with pibrentasvir, or sofosbuvir with velpatasvir and voxilaprevir, as they may cause elevated liver function tests (increased levels of the liver enzyme ALT).
Your doctor will recommend a suitable contraceptive method before starting these medications. You can restart Sylvie 20, Sylvie 30 about 2 weeks after finishing these medications. See section 2 "When not to take Sylvie 20, Sylvie 30".
Note: You should read the information about concomitant use of medications to recognize possible interactions.
Before taking any medication, you should consult your doctor.
Sylvie 20, Sylvie 30 should not be taken during pregnancy or if pregnancy is suspected.
If pregnancy is suspected, you should see your doctor as soon as possible.
Sylvie 20, Sylvie 30 is not recommended during breastfeeding.
No effect of Sylvie 20, Sylvie 30 on the ability to drive and use machines has been observed.
You should see your doctor immediately if:
8
The situations and symptoms listed above are described in more detail in other parts of this leaflet.
If you have been diagnosed with an intolerance to some sugars, you should consult your doctor before taking Sylvie 20, Sylvie 30.
The medication contains less than 1 mmol (23 mg) of sodium per sugar-coated tablet, which means the medication is considered "sodium-free".
This medication should always be taken as directed by your doctor or pharmacist. If you have any doubts, you should consult your doctor or pharmacist.
The leaflet describes many situations in which you should not take Sylvie 20, Sylvie 30 or in which the effectiveness of the medication may be reduced. It also lists circumstances in which you should not have sexual intercourse or should use additional contraceptive methods, such as condoms or other barrier methods. The calendar method and temperature measurement method cannot be used, as Sylvie 20, Sylvie 30 affects temperature changes and cervical mucus properties characteristic of the menstrual cycle.
The blister pack contains 21 tablets. On the packaging, each tablet is marked with the day of the week on which it should be taken. You should take one tablet of Sylvie 20, Sylvie 30 every day, in the order indicated by the arrows on the packaging, every day, at about the same time, with a small amount of liquid if necessary. For 21 consecutive days, take one tablet per day. Then, do not take any tablets for 7 days. During this 7-day break, during which you do not take tablets ("tablet-free interval"), you will usually start withdrawal bleeding. This so-called "withdrawal bleeding" usually starts 2-3 days after taking the last tablet and may last until the next pack is started. This means that you will always start each new pack on the same day of the week, and your bleeding will occur at about the same time each cycle.
Take the first tablet in the pack on the first day of your period (the first day of menstrual bleeding). You can also start taking the tablets between the 2nd and 5th day of your period, but during the first cycle, you should use additional mechanical contraception (e.g., condoms) for the first 7 days.
Start taking Sylvie 20, Sylvie 30 the next day after taking the last active tablet of your previous contraceptive (this means no break in taking tablets). If your previous contraceptive also contains inactive tablets (placebo), you can start taking Sylvie 20, Sylvie 30 the next day after taking the last active tablet (if you are unsure which tablet is which, ask your doctor or pharmacist). You can also start taking Sylvie 20, Sylvie 30 later, but no later than the day you would have taken the next active tablet (or the next placebo tablet of your previous contraceptive).
In the case of a vaginal ring or transdermal patch, you should start taking Sylvie 20, Sylvie 30 on the day the ring or patch is removed, but no later than the day you would have applied a new ring or patch. If you follow these recommendations, you do not need to use additional contraceptive methods.
You can stop taking the mini-pill at any time and start taking Sylvie 20, Sylvie 30 at the same time. If you have sexual intercourse during the first 7 days of taking Sylvie 20, Sylvie 30, you should use additional mechanical contraception.
Start taking Sylvie 20, Sylvie 30 on the day you would have had your next injection or on the day the implant or intrauterine system is removed. If you have sexual intercourse during the first 7 days of taking the tablets, you should use additional mechanical contraception.
After childbirth, miscarriage, or abortion
You can start taking Sylvie 20, Sylvie 30 immediately. In this case, you do not need to use additional contraceptive methods.
Your doctor should inform you that you should start taking the tablets 21 to 28 days after childbirth or miscarriage in the second trimester. If you start taking the tablets later, your doctor should advise you to use additional mechanical contraception for the first 7 days of taking the tablets. If you have had sexual intercourse before starting Sylvie 20, Sylvie 30, you should make sure you are not pregnant or wait for your first menstrual period.
10
Nausea, vomiting, or vaginal bleeding (especially in young girls) may occur. There have been no reports of serious side effects after taking multiple tablets of Sylvie 20, Sylvie 30 at the same time.
If you have taken more than the recommended dose of Sylvie 20, Sylvie 30 or if a child has taken some, you should ask your doctor or pharmacist for advice.
Sylvie 20, Sylvie 30 can be stopped at any time. Your doctor will recommend another contraceptive method if you do not want to become pregnant. If you stop taking Sylvie 20, Sylvie 30 because you want to become pregnant, you should wait until you have had a natural menstrual period. This will help you determine the expected date of delivery.
If it has been less than 12 hourssince you missed a tablet, the contraceptive effectiveness of Sylvie 20, Sylvie 30 is maintained. You should take the missed tablet as soon as possible and take the next tablet at the usual time.
If it has been more than 12 hourssince you missed a tablet, the effectiveness of Sylvie 20, Sylvie 30 may be reduced. The more tablets you miss, the higher the risk of reduced contraceptive effectiveness.
There is a particularly high risk of pregnancy if you miss tablets at the beginning or end of the pack. In this case, you should follow the rules below (see also the diagram below).
You should consult your doctor.
Take the missed tablet as soon as possible, even if it means taking two tablets at the same time, and continue taking the tablets at the usual time. Use additional mechanical contraception for the next 7 days.
If you had sexual intercourse during the week before missing the tablet, it is possible that you may become pregnant. You should see your doctor as soon as possible.
Take the missed tablet as soon as possible, even if it means taking two tablets at the same time, and continue taking the tablets at the usual time. The contraceptive effectiveness of Sylvie 20, Sylvie 30 is not reduced, and you do not need to use additional contraceptive methods. However, if you made a mistake when taking the tablets earlier or missed more than one tablet, you should use additional mechanical contraception for 7 days.
You can choose one of the following options without the need for additional contraceptive methods, provided you have taken the tablets correctly for the preceding 7 days. If not, you should follow the first of the two options below and use additional mechanical contraception for 7 days.
11
If you miss a tablet and do not have withdrawal bleeding during the tablet-free interval, you may be pregnant. You should see your doctor before starting the next pack.
Missed more than
1 tablet from the pack
consult your doctor
had sexual intercourse
in the week before missing
the tablet
Tydzień 1.
did not have sexual intercourse
or
Tydzień 3.
13
Like any drug, this drug can cause side effects, although they may not occur in everyone. If any side effects occur, especially severe and persistent ones or changes in health that the patient considers related to the use of the Sylvie 20, Sylvie 30 drug, you should consult a doctor.
14
In all women using combined hormonal contraceptives, there is an increased risk of blood clots in the veins (venous thromboembolic disease) or blood clots in the arteries (arterial thromboembolic disease). For detailed information on the various risk factors associated with the use of combined hormonal contraceptives, refer to section 2 "Important information before using the Sylvie 20, Sylvie 30 drug”.
Severe side effects related to the intake of the Sylvie 20, Sylvie 30 drug and their symptoms are described in the following parts of the leaflet: "Oral contraception and cancer", "Blood clots". You should read these sections to obtain additional information and, if necessary, immediately consult a doctor.
You should immediately contact a doctor if the patient experiences any of the following symptoms of angioedema: facial swelling, tongue and/or throat swelling, and/or difficulty swallowing or urticaria, potentially with breathing difficulties (see also the "Warnings and precautions" section).
Below are the symptoms reported by patients taking the Sylvie 20, Sylvie 30 drug, although they may not have been caused by the drug.
Often(may occur in less than 1 in 10 people):
Not very often(may occur in less than 1 in 100 people):
Rarely(may occur in less than 1 in 1,000 people):
15
The likelihood of blood clots may be higher if the patient has any other risk factors (see section 2 for further information on risk factors for blood clots and symptoms of blood clots).
In women with hereditary angioedema, exogenous estrogens (e.g., in the form of this drug) may cause the occurrence or exacerbation of its symptoms.
In some people, during the use of the Sylvie 20, Sylvie 30 drug, other side effects may occur.
If any side effects occur, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist about them. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be gathered on the safety of the drug.
The drug should be stored out of sight and reach of children.
Do not store above 30°C.
Store in the original packaging.
Do not use this drug after the expiration date stated on the box and blister pack after: EXP.
The expiration date means the last day of the given month.
Drugs should not be disposed of in the sewage system or household waste containers. You should ask your pharmacist how to dispose of unused drugs. This will help protect the environment.
The active substances are:
ethinylestradiol: 20 micrograms and gestodene: 75 micrograms (Sylvie 20)
or
ethinylestradiol: 30 micrograms and gestodene: 75 micrograms (Sylvie 30)
Other ingredients are:
Core of the tablet:
Sodium-calcium versenate
Lactose monohydrate
Corn starch
Magnesium stearate
Povidone 25
Coating:
Sucrose
16
Povidone 90 F
Calcium carbonate
Macrogol 6000
Talc
Montan glycol wax
Sylvie 20, Sylvie 30 are round sugar-coated tablets. Each package of Sylvie 20, Sylvie 30 contains one (three or six) calendar package of 21 film-coated tablets.
Farmak International Sp. z o.o.
ul. Koszykowa 65
00-667 Warsaw
Farmak International Sp. z o.o.
ul. Chełmżyńska 249
04-458 Warsaw
Poland
Poland: Sylvie 20, Sylvie 30
Date of last revision of the leaflet:May 2025
17
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.